Loading...
 
Mediterr J Rheumatol 2018;29(3):178-81
ACTH vs betamethasone for the treatment of acute gout in hospitalized patients: A randomized, open label, comparative study
Authors Information

University Hospital of Patras

References
  1. Khanna D, Khanna P P, Fitzgerald J D, Singh M K, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012;64:1447-61. [https://doi.org/10.1002/acr.21772] [PMID: 23024028]
  2. Keenan R T, O'Brien W R, Lee K H, Crittenden D B, Fisher M C, Goldfarb D S, et al. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med 2011;124:155-63. [https://doi.org/10.1016/j.amjmed.2010.09.012] [PMID: 21295195]
  3. Daoussis D, Antonopoulos I, Andonopoulos AP. ACTH as a treatment for acute crystal-induced arthritis: update on clinical evidence and mechanisms of action. Semin Arthritis Rheum 2014; 43:648-53. [https://doi.org/10.1016/j.semarthrit.2013.09.006] [PMID: 24762710]
  4. Siegel L B, Alloway J A, Nashel D J. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J Rheumatol 1994;21:1325-7. [PMID: 7966077]
  5. Axelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988;31:803-5. [PMID: 2454635]
  6. Ritter J, Kerr L D, Valeriano-Marcet J, Spiera H. ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J Rheumatol 1994;21:696-9. [PMID: 8035395]
  7. Getting S J, Christian H C, Flower R J, Perretti M. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 2002;46:2765-75. [https://doi.org/10.1002/art.10526] [PMID: 12384937]
  8. Getting S J, Lam C W, Chen A S, Grieco P, Perretti M. Melanocortin 3 receptors control crystal-induced inflammation. FASEB J 2006;20:2234-41. [https://doi.org/10.1096/fj.06-6339com] [PMID: 17077300]
  9. Daoussis D, Antonopoulos I, Yiannopoulos G, Andonopoulos A P. ACTH as first line treatment for acute gout in 181 hospitalized patients. Joint Bone Spine 2013;80:291-4. [https://doi.org/10.1016/j.jbspin.2012.09.009] [PMID: 23195793]
  10. Mitroulis I, Kambas K, Chrysanthopoulou A, Skendros P, Apostolidou E, Kourtzelis I, et al. Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout. PLoS One 2011;6:e29318. [https://doi.org/10.1371/journal.pone.0029318] [PMID: 22195044]
  11. Gavillet M, Martinod K, Renella R, Harris C, Shapiro N I, Wagner D D, et al. Flow cytometric assay for direct quantification of neutrophil extracellular traps in blood samples. Am J Hematol 2015;90:1155-8. [https://doi.org/10.1002/ajh.24185] [PMID: 26347989]